My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Pharmaqo Labs Pharmaqo Labs
IGF DES 1-3
IGF DES 1-3 - Pharmaqo Labs

IGF DES 1-3 - Pharmaqo Labs

Brand:
Pharmaqo Labs
Category:
Peptides
Substance:
Insulin-like Growth Factor-1-DES
Package:
1 mg
Price:
0
See options
Product Overview

Due to its reduced binding affinity to IGFBPs, IGF-1 DES can achieve greater concentrations in targeted areas, enhancing its anabolic and hypoglycemic effects. This property has made IGF-1 DES a popular molecule in research, especially for its potential applications in cellular regeneration and glial proliferation in the central nervous system. Studies suggest that IGF-1 DES might promote faster wound repair, making it a candidate for investigations into neuroprotection and recovery after neuronal injury, though its effects vary depending on dose and administration.

References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers. 

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about IGF DES 1-3 by Pharmaqo Labs, consult with your doctor or healthcare professional.

Explore More Products
Reviews
Leave Review
FAQ
Why is IGF-1 DES considered more potent in vitro?
It has reduced binding to IGFBPs, increasing its free concentration, which enhances its effectiveness at cellular targets.
References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers. 

What are IGFBPs?
IGFBPs are Insulin-like Growth Factor Binding Proteins that regulate IGF availability and activity in the body.
References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers. 

Why does IGF-1 DES interact less with IGFBPs?
Its truncated structure reduces its affinity for IGFBPs, allowing it to bypass some regulatory constraints.
References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers.